Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

612 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy.
Fine A, Zacharias J. Fine A, et al. Kidney Int. 2002 Jun;61(6):2210-7. doi: 10.1046/j.1523-1755.2002.00375.x. Kidney Int. 2002. PMID: 12028462
As well, a case control study, with two controls per patient, was performed on patients presenting with non-ulcerating plaques. RESULTS: The incidence of calciphylaxis in dialysis patients increased with a rate of 4.5/100 patient-years in the past three years. ...
As well, a case control study, with two controls per patient, was performed on patients presenting with non-ulcerating plaques. RESUL …
Calciphylaxis: the beginning of the end?
Fine A, Fontaine B. Fine A, et al. Perit Dial Int. 2008 May-Jun;28(3):268-70. Perit Dial Int. 2008. PMID: 18474919
BACKGROUND: We previously reported a very high incidence of calciphylaxis, mainly in peritoneal dialysis (PD) patients. Although we identified several risk factors for the condition, including PD, we were unable to identify why our particular unit had such a high fr …
BACKGROUND: We previously reported a very high incidence of calciphylaxis, mainly in peritoneal dialysis (PD) patients. Although we i …
Nephrologists should voluntarily divulge survival data to potential dialysis patients: a questionnaire study.
Fine A, Fontaine B, Kraushar MM, Rich BR. Fine A, et al. Perit Dial Int. 2005 May-Jun;25(3):269-73. Perit Dial Int. 2005. PMID: 15981775
METHOD: A questionnaire was completed by 100 general nephrology patients during their first visit to a nephrologist. RESULTS: The vast majority of patients (97%) would want to be given life-expectancy information, and for the physician to do so without having to be …
METHOD: A questionnaire was completed by 100 general nephrology patients during their first visit to a nephrologist. RESULTS: …
Hospitalization is not necessary for peritoneal dialysis catheter insertion.
Verrelli M, Fontaine B, Kraushar M, Fine A. Verrelli M, et al. Perit Dial Int. 2002 Sep-Oct;22(5):614-6. Perit Dial Int. 2002. PMID: 12455573 Clinical Trial. No abstract available.
Challenging the current treatment paradigm for methicillin-resistant Staphylococcus epidermidis peritonitis in peritoneal dialysis patients.
Ariano RE, Franczuk C, Fine A, Harding GK, Zelenitsky SA. Ariano RE, et al. Perit Dial Int. 2002 May-Jun;22(3):335-8. Perit Dial Int. 2002. PMID: 12227390
OBJECTIVES: To analyze clinical outcomes of Staphylococcus epidermidis peritoneal dialysis peritonitis before and after an interventional switch from a vancomycin/ tobramycin to a cefazolin/tobramycin regimen for empiric treatment. ...DESIGN: A retrospective …
OBJECTIVES: To analyze clinical outcomes of Staphylococcus epidermidis peritoneal dialysis peritonitis before and after an interventional sw …
Relevance of C-reactive protein levels in peritoneal dialysis patients.
Fine A. Fine A. Kidney Int. 2002 Feb;61(2):615-20. doi: 10.1046/j.1523-1755.2002.00145.x. Kidney Int. 2002. PMID: 11849404
METHODS: A chart review of 190 prevalent peritoneal dialysis patients was performed. CRP, albumin, ferritin, erythropoietin (EPO) dose and resistance, Kt/V, and residual renal function values were obtained and a history or presence of cardiovascular disease (CAD, PV …
METHODS: A chart review of 190 prevalent peritoneal dialysis patients was performed. CRP, albumin, ferritin, erythropoietin (EPO) dos …
Antibiotic tolerance of peritoneal bacterial isolates in dialysis fluids.
Zelenitsky S, Franczuk C, Fine A, Ariano R, Harding G. Zelenitsky S, et al. J Antimicrob Chemother. 2002 May;49(5):863-6. doi: 10.1093/jac/dkf006. J Antimicrob Chemother. 2002. PMID: 12003985
Atheroma progression in chronic kidney disease.
Rigatto C, Levin A, House AA, Barrett B, Carlisle E, Fine A. Rigatto C, et al. Clin J Am Soc Nephrol. 2009 Feb;4(2):291-8. doi: 10.2215/CJN.01840408. Epub 2009 Jan 14. Clin J Am Soc Nephrol. 2009. PMID: 19144763 Free PMC article. Clinical Trial.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We performed a prospective cohort study in 318 prevalent CKD patients with initial creatinine clearance (CCr) between 20 and 50 ml/min/1.73 m(2). ...A secondary analysis using quintiles of Modification of Diet in Re …
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We performed a prospective cohort study in 318 prevalent CKD patients with initial …
Adequacy of a vancomycin dosing regimen in patients receiving high-flux hemodialysis.
Ariano RE, Fine A, Sitar DS, Rexrode S, Zelenitsky SA. Ariano RE, et al. Am J Kidney Dis. 2005 Oct;46(4):681-7. doi: 10.1053/j.ajkd.2005.07.018. Am J Kidney Dis. 2005. PMID: 16183423
Average amount of vancomycin removed during a standardized 3- to 4-hour dialytic session ranged from 30% +/- 7% to 38% +/- 8%. ...The lack of drug accumulation with this regimen provides convincing support for a limited blood sampling approach to plasma concentratio …
Average amount of vancomycin removed during a standardized 3- to 4-hour dialytic session ranged from 30% +/- 7% to 38% +/- 8%. ...The …
612 results
Jump to page
Feedback